Secukinumab Rapidly Improves Disease Severity in Mild to Moderate Psoriasis - HCPLive

Retrieved on: 2023-10-22 18:48:10

Tags for this article:

Autoimmune diseases

Psoriasis

Orphan drugs

Placebo

Calcipotriol/betamethasone dipropionate

Bruce E Strober

Secukinumab

Click the tags to see associated articles and topics

Secukinumab Rapidly Improves Disease Severity in Mild to Moderate Psoriasis - HCPLive. View article details on HISWAI: https://www.hcplive.com/view/secukinumab-rapidly-improves-disease-severity-in-mild-to-moderate-psoriasis

Excerpt

The drug, a fully human monoclonal antibody designed to selective neutralize interleukin (IL)-17A, has previously demonstrated long-term efficacy ...

Article found on: www.hcplive.com

View Original Article